Inclusion Criteria:  Diagnosed with cataract requiring surgery according to current guidelines; Eligible to lens removal by phacoemulsification and replacement by a prosthetic lens under local anesthesia; Who have been informed and gave informed consent to participate in the study.  Exclusion Criteria:  Eye with an anterior chamber depth < 2.5 mm or > 3.8 mm; Corneal disease or pathology that precludes applanation of the cornea or transmission of laser wavelength or distortion of laser light; Eye with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally; Patient with residual, recurrent, active ocular or eyelid disease, including any corneal abnormality (for example, recurrent corneal erosion, severe basement membrane disease) in either eye; History of steroid-responsive rise in IOP, glaucoma, or preoperative IOP>21 mm Hg in either eye; Lens/zonular instability such as, but not restricted to, Marfan's Syndrome, pseudoexfoliation syndrome, etc; Previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye; Any recent penetrating incision of the eyeball; Tilt of lens > 7; Presence of any obstacle that may interfere with the stabilization of the device on the limbus: pterygium, limbic tumor, etc; Pregnant or lactating woman; Patient with any contra-indication to neosynephrine, tropicamide and oxybuprocaïne; Patient presenting any contraindications to cataract surgery under local anesthesia (ex: allergy to anesthetic drops; neurodegenerative disease; schizophrenia; severe anxiety; etc.); Patient who participates to another clinical trial (except observational studies), or in the exclusion period of another clinical trial; Patient under guardianship, trusteeship or deprived of liberty; Patient not affiliated to the French social security system; Patient unable to participate in the study for psychiatric, cognitive or linguistic reasons.